基本信息
浏览量:1
职业迁徙
个人简介
Dr. Gilbert has published over 230 peer-reviewed manuscripts, has numerous patents, is frequently invited as a keynote speaker at major international conferences, and co-founded Fibrotech, a biotechnology company that has brought novel anti-fibrotic therapies from the bench to early phase human trials. Following Fibrotech’s acquisition in 2014, Dr. Gilbert then founded another biotech company, Fibrocor Therapeutics, and is currently its Chief Scientific Officer designing and overseeing research projects that lead to the development of new therapies for the prevention and treatment of diseases of fibrosis such as cirrhotic liver disease, pulmonary fibrosis, chronic kidney disease and heart failure. In addition to his bench research, Dr. Gilbert is actively involved in teaching and knowledge translation with membership of Guidelines Committees for CHEP and Diabetes Canada on the management of hypertension, heart failure and chronic kidney disease in diabetes.
研究兴趣
论文共 360 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Diabetes research and clinical practice (2023): 110946-110946
引用0浏览0WOS引用
0
0
B. E. R. T. R. A. M. PITT, B. A. R. R. Y. REICHER,R. I. C. H. A. R. D. GILBERT, B. E. N. J. A. M. I. N. SCIRICA,K. A. R. L. SWEDBERG,A. N. N. A. LANGKILDE, J. O. H. N. MONYAK, N. A. T. A. L. I. A. ZAOZERSKA,M. I. K. H. A. I. L. KOSIBOROD
Kyle Chin, Hannah Joo, Iryna Savinova, Helen Jiang, Chloe Lin, Melina Cazorla-Bak,Jeremy Simpson,Kim Connelly,Richard Gilbert,Andrew Baker,C. David Mazer,William Darrah,
JACC. Cardiovascular imagingno. 6 (2021): 1164-1173
Physiological Reportsno. 9 (2019)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn